I have just listened to that Interview. Having done so, I am in no way surprised to see the SP rise. What they are targeting is a phenomenal disruptive tech that will blow existing business models in medical fields out of the water. Going to have to think 2 years out, but I am happy to add a few more to the pot, in full knowledge there has to be a cap raising at some point, UNLESS a major pharma comes in to support them which I think is a very likely option. Craigs quote was that pharma approached them to be involved in the roll out phase. They are clearly keen.
Probably the best interview I have seen from anyone in years
Add to My Watchlist
What is My Watchlist?
